Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

peginesatide

Known as: Erythropoiesis-Stimulating Agent (ESA) 
A synthetic, non-recombinant, pegylated, peptidic erythropoiesis stimulating agent. Synthetic peptide-based erythropoiesis stimulating agent binds to… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The UK-based National Institute for Health and Care Excellence (NICE) has updated its guidance on iron deficiency and anemia… Expand
Is this relevant?
2015
2015
BACKGROUND In haemodialysis (HD) patients, anaemia is associated with reduced survival. Despite treatment with erythropoiesis… Expand
  • table 1
Is this relevant?
2013
2013
BACKGROUND Peginesatide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), is a potential therapy for anemia in… Expand
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
BACKGROUND Peginesatide is a peptide-based erythropoiesis-stimulating agent (ESA) that may have therapeutic potential for anemia… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2012
Review
2012
BACKGROUND The anaemia seen in chronic kidney disease (CKD) may be exacerbated by iron deficiency. Iron can be provided through… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Intravenous (i.v.) iron sucrose similar (ISS) preparations are available but clinical comparisons with the originator… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Shortening of red blood cell (RBC) survival contributes to the anemia of chronic kidney disease. The toxic uremic… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Randomized trials have endeavored to show that using ESAs to raise hemoglobin concentrations to higher targets improves clinical… Expand
Is this relevant?
Review
2009
Review
2009
Randomized controlled trials (RCTs) clearly indicate a possible cardiovascular morbidity and mortality risk when deliberately… Expand
Is this relevant?
2008
2008
Patients with myelodysplastic syndromes (MDS) often develop anaemia resulting in frequent transfusions and fatigue. Darbepoetin… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • table II
Is this relevant?